Navigation Links
Omnicell to Release First Quarter 2009 Earnings Results on April 30
Date:4/24/2009

MOUNTAIN VIEW, Calif., April 24 /PRNewswire-FirstCall/ -- Omnicell, Inc. (Nasdaq: OMCL), a leading provider of system solutions to acute healthcare facilities, will hold a conference call Thursday, April 30 to discuss the Company's First Quarter 2009 financial results.

    What:      Omnicell First Quarter 2009 earnings conference call and
               webcast
    When:      April 30, 2009, 1:30 p.m. PDT
    Who:       Randall Lipps, chairman, president and chief executive officer
               Rob Seim, chief financial officer
    Where:     The conference call can be monitored by dialing 1-800-696-5518
               within the U.S. or 1-706-758-4883 for all other locations.
               The Conference ID # is 96508596.
               The webcast can be accessed at:
              http://ir.omnicell.com/events.cfm.

Omnicell Conference Call Information

Omnicell will hold a conference call on April 30 at 1:30 p.m. PDT to discuss first quarter financial results. The conference call can be monitored by dialing 1-800-696-5518 within the U.S. or 1-706-758-4883 for all other locations. The Conference ID # is 96508596. Internet users can access the conference call at http://ir.omnicell.com/events.cfm. A replay of the call will be available today at approximately 2:30 p.m. PDT and will be available until 8:59 pm PDT on May 7. The replay access numbers are 1-800-642-1687 within the U.S. and 1-706-645-9291 for all other locations, conference code # 96508596.

    How:       Link to the Omnicell website 15 minutes prior to the call to
               download necessary audio software.
    Replay:    Available starting at 2:30 p.m. PDT on April 30, 2009
               through 8:59 p.m. PDT on May 7.  Dial 1-800-642-1687 within the
               U.S. and 1-706-645-9291 for all other locations,
               Conference ID # 96508596.

About Omnicell

Omnicell, Inc. (NASDAQ: OMCL) is a leading provider of systems and software solutions targeting patient safety and operational efficiency in healthcare facilities. Since 1992, Omnicell has worked to enhance patient safety and allow clinicians to spend more time with their patients.

Omnicell's medication-use product line includes solutions for the central pharmacy, nursing unit, operating room, and patient bedside. Solutions range from large central pharmacy smart inventory carousels to small handheld devices. From the point at which a medication arrives at the receiving dock to the time it is administered, Omnicell systems store it, package it, bar code it, order it, issue it, and provide information and controls on its use and reorder.

Our supply product lines provide a healthcare institution with fast, effective control of costs, capture of charges for payer reimbursement, and timely reorder of supplies. Products range from high-security closed-cabinet systems and software to open-shelf and combination solutions in the nursing unit, catheter lab and operating room.

Omnicell's mission is to provide the best customer experience in healthcare, helping hospitals reduce medication errors, operate more efficiently, and decrease costs. For more information, visit www.omnicell.com.

OMCL-E


'/>"/>
SOURCE Omnicell, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Omnicell Unveils Tissue Center Solution - Industrys First Integrated Tissue Tracking and Compliance System
2. Shands HealthCare Increases Operational Efficiency in Surgical Suites With Omnicell Supply Systems
3. Omnicell is Awarded Contract by Major National Academic Medical Center
4. Omnicell is Awarded Sole-source Contract by Emory Healthcare
5. Omnicell to Release Fourth Quarter 2008 Earnings Results on January 29
6. Omnicell Updates 2008 Year End Guidance and Announces Company Reorganization
7. Brigham and Womens Hospital Selects SinglePointe(TM) Automated Patient-Specific Medication Management Solution from Omnicell
8. Omnicell Attains Microsoft Gold Certified Partner Status
9. Omnicell to Present at Piper Jaffray 20th Annual Healthcare Conference
10. Omnicell to Release Second Quarter 2008 Earnings Results on July 21
11. University of Tennessee Medical Center Initiates Patient-Specific Medication Management With SinglePointe(TM) Solution From Omnicell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel ... a portion of proceeds to two local organizations: North Chicago Animal Control and Friends ... is a team of authorized and trained volunteers who support rescued animals held ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... "ProBrand Flip ... and all media," said Christina Austin - CEO of Pixel Film Studios. , ProBrand ... easy to use drop zones. Editors can select from a variety of flip book ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Tomorrow Trump Goes To Washington”: a ... to the presidency and to America. “Tomorrow Trump Goes To Washington” is the creation ... she can for this country. , Nancy attributes her patriotic nature to her WWII ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... to present at the International Probiotic Association’s Washington DC workshop on November 2nd. ... to engage in dialog regarding probiotic dietary supplement regulations. , Dr. Leyer ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... because of a higher risk of serious health problems, such as cardiovascular illness, ... Dr. Peiman Soleymani of Beverly Hills Periodontics & Dental Implant Center notes that ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... WESTLAKE VILLAGE, Calif. , Dec. 6, ... a privately held, clinical-stage medical dermatology and ... Creabilis plc, a privately held specialty pharmaceutical ... for common inflammatory skin conditions, including psoriasis, ... terms of the agreement, Sienna will make ...
(Date:12/6/2016)... Calif. , Dec. 6, 2016  Regulus ... biopharmaceutical company leading the discovery and development of ... drug development candidates at its R&D day, held ... first candidate, RGLS5040, is an anti-miR targeting microRNA-27 ... second candidate, RGLS4326, is an anti-miR targeting microRNA-17 ...
(Date:12/6/2016)... - InMed Pharmaceuticals, Inc. ("InMed") (CSE: IN; OTCQB: ... in the use of cannabinoids for the treatment ... 2015 InMed initiated its COPD program using its ... potential active compounds that can be useful for ... assays using human lung fibroblasts (HFL-1 cell line), ...
Breaking Medicine Technology: